C45H69N11O12S
Quick Details
|
Product Name |
carbetocin |
|
CAS |
37025-55-1 |
|
Molecular Formula |
C45H69N11O12S |
|
Molecular Weight |
988.161 |
|
Application |
Used felective epidural lumbar surgery |
|
Purity |
98% |
|
storage |
Short-term 2 ℃ 8 ℃, long - 20 ℃ |
Description
indications
Capecycin is used to prevent uterine insufficiency postpartum bleeding by elective epidural lumbar anesthesia after caesarean sections.
No studies have been conducted on the use of capectal intrauterine in emergency caesarean sections, classic caesarean sections, epidural other anesthetic caesarean sections in women with a significant history of heart disease, hypertension, known coagulation liver, kidney endocrine diseases (not including gestational diabetes). There has been no proper study on the administration of capectal intrauterine therapy after vaginal delivery, the dosage has not been determined
Usage.
A single dose of intravenous injection of 100 micrograms (1 milliliter) of capectal intrauterine was administered slowly once within 1 minute after cesarean section was performed under epidural lumbar anesthesia. Oxytocin may be given before after delivery of the placenta, as directed by the physician
Adverse reactions
Adverse events of oxytocin were observed in clinical trials in the same form frequency as those observed after cesarean section under epidural lumbar anesthesia.
Nausea, abdominal pain, itching, redness, vomiting, heat, low blood pressure, headache tremors are common after intravenous injection of capecycin (10-40%).
Rare adverse events (1-5%) include back pain, dizziness, metallic taste, anaemia, sweating, chest pain, dyspnea, chills, tachycardia anxiety
